Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-049118

President and CEO sold 18,334 shares at $18.05 ($330,929)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-08-29 Sale : show line 1 in the form −18,334 $18.05 $330,929 2,784,304 I
Open-market sales · 18,334 sh · avg $18.05 · $330,929
Loading xslF345X03/doc4.xml…